Sermorelin is almost never billable to insurance because it is a compounded preparation, not an FDA-approved finished drug. The practical workaround most patients use is an HSA or FSA, which generally covers prescribed sermorelin.
Compounded sermorelin is rarely covered by health insurance. The reason is structural: insurers reimburse FDA-approved finished drugs, and compounded sermorelin is prepared by a licensed pharmacy for an individual prescription rather than manufactured and approved as a finished product. Almost every sermorelin program runs as cash-pay. The good news for most patients is that HSA and FSA funds generally do apply.
- Compounded sermorelin is almost never covered by commercial insurance or Medicare
- The reason is that it is a compounded preparation, not an FDA-approved finished drug
- HSA and FSA funds generally cover prescribed sermorelin as a qualified medical expense
- Programs run cash-pay, so the all-in monthly cost is what matters
- Confirm HSA or FSA eligibility and ask for an itemized receipt before paying
Why Insurance Does Not Cover It
Insurance formularies are built around FDA-approved finished drugs with assigned billing codes. Compounded sermorelin does not fit that model. The original branded sermorelin product, Geref, was withdrawn from the market in 2008 for commercial reasons, which left compounding as the route through which sermorelin is now prescribed. Because compounded preparations are made for individual prescriptions under 503A or 503B rules rather than approved as finished products (FDA [1]), they generally fall outside what insurers will reimburse.
This is not unique to sermorelin. Most compounded medications face the same coverage gap regardless of the active ingredient. Treat any program that implies insurance will cover sermorelin with caution, and confirm the all-in cash price before starting.
Using HSA and FSA Funds
HSA and FSA accounts are the practical path most patients use. Prescribed sermorelin is generally a qualified medical expense because it is a medication prescribed by a licensed provider for a diagnosed condition. The IRS defines qualified medical expenses in Publication 502, and HSA and FSA rules are detailed in Publication 969 (IRS [2][3]). Most telehealth sermorelin platforms accept HSA and FSA cards directly at checkout.
- Confirm the provider accepts HSA or FSA cards, or can issue an itemized receipt
- Keep the prescription record and an itemized receipt showing the medication and provider
- Pay with the HSA or FSA card directly, or submit the receipt for reimbursement
- Retain documentation in case your plan administrator requests substantiation
HSA and FSA administrators can ask you to substantiate an expense. An itemized receipt that names the prescribed medication, the date, and the prescribing provider is usually sufficient. A generic credit card receipt is not.
What the Cash Cost Looks Like
Because sermorelin is cash-pay, the number that matters is the all-in monthly cost, not the advertised starting price. Compounded sermorelin runs from roughly 79 to 329 dollars per month depending on the provider, dose, and protocol. Some programs bundle the consultation and follow-up labs into that figure, while others bill the baseline IGF-1 and consultation separately. A low headline price with labs and fees added on top can cost more than a higher all-inclusive plan.
- Compare the all-in monthly cost, including consultation and labs, not the starting price
- Ask whether the baseline IGF-1 and 90-day retest are included or billed separately
- Confirm shipping and any membership fees up front
- A program that hides pricing until after a consultation call is a consistent red flag
Bottom Line
Plan for sermorelin as a cash-pay therapy. Commercial insurance and Medicare almost never cover compounded sermorelin because it is not an FDA-approved finished drug. HSA and FSA funds generally do apply, which is the route most patients use, provided you keep an itemized receipt. Compare providers on the all-in monthly cost rather than the advertised entry price.
Frequently Asked Questions
Does insurance cover sermorelin?
Almost never. Commercial insurance and Medicare reimburse FDA-approved finished drugs, and compounded sermorelin is prepared by a licensed pharmacy for an individual prescription rather than approved as a finished product. As a result, sermorelin programs run as cash-pay. Be cautious of any provider that implies insurance will cover it.
Can I use my HSA or FSA for sermorelin?
Generally yes. Prescribed sermorelin is typically a qualified medical expense because it is a medication prescribed by a licensed provider. IRS Publication 502 defines qualified medical expenses and Publication 969 covers HSA and FSA rules. Most telehealth platforms accept HSA and FSA cards at checkout. Keep an itemized receipt in case your administrator requests substantiation.
Why is sermorelin not covered by insurance?
Insurance formularies are built around FDA-approved finished drugs with billing codes. Compounded sermorelin does not fit that model because it is made for individual prescriptions under 503A or 503B compounding rules rather than approved as a finished product. The original branded product, Geref, was withdrawn in 2008 for commercial reasons, leaving compounding as the route sermorelin is now prescribed.
How much does sermorelin cost without insurance?
Compounded sermorelin runs from roughly 79 to 329 dollars per month depending on the provider, dose, and protocol. Because it is cash-pay, the all-in monthly cost is what matters. Some programs bundle the consultation and follow-up labs into the price, while others bill the baseline IGF-1 and consultation separately, so compare total cost rather than the advertised starting price.
Will Medicare pay for sermorelin?
No. Medicare does not cover compounded sermorelin for the same reason commercial insurers do not: it is a compounded preparation rather than an FDA-approved finished drug. Patients on Medicare pay cash. HSA funds are generally not available alongside Medicare, but an FSA through an employer or other qualified funds may still apply.
References
- Compounding laws and policies (503A and 503B) fda.gov, 2024. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- Publication 502: Medical and Dental Expenses irs.gov, 2025. https://www.irs.gov/publications/p502
- Publication 969: Health Savings Accounts and Other Tax-Favored Health Plans irs.gov, 2025. https://www.irs.gov/publications/p969
